Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT2 | Q96KQ7 | 3/20 | 0.33 |
| ▸ | EHMT1 | Q9H9B1 | 3/20 | 0.33 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | GSDMD | P57764 | 2/20 | 0.33 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | PHGDH | O43175 | 1/20 | 0.32 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.32 |
| ▸ | GMNN | O75496 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1119578 | 0.97 | EHMT2 (0.35) | EHMT2EHMT1ABCB11HTTGSDMD | |
| Bromide SCHEMBL262065 | 0.94 | EHMT2 (0.33) | EHMT2EHMT1ABCB11HTTGSDMD | |
| Hydrochloric Acid SCHEMBL261161 | 0.94 | EHMT2 (0.33) | EHMT2EHMT1ABCB11HTTGSDMD | |
| Iodide SCHEMBL7033668 | 0.94 | EHMT2 (0.33) | EHMT2EHMT1ABCB11HTTGSDMD | |
| Hydrochloric Acid SCHEMBL27913333 | 0.94 | EHMT2 (0.33) | EHMT2EHMT1ABCB11HTTGSDMD | |
| SCHEMBL7032131 | 0.87 | — | — | |
| SCHEMBL8717245 | 0.85 | CA12 (0.37) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL7035110 | 0.85 | TSHR (0.39) | LMNAALDH1A1TSHR | |
| Hydrochloric Acid SCHEMBL25405995 | 0.83 | CA12 (0.36) | CA12CA1CA2CA9TSHR | |
| Acetic Acid SCHEMBL261148 | 0.83 | CA1 (0.36) | CA1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114621178-A | Preparation process of fluoroethylene carbonate | 内蒙古源宏精细化工有限公司 | 2022-06-14 | — | — | CN | claimed |
| CN-112441876-B | Synthetic method of octafluorotoluene | 大连奇凯医药科技有限公司 | 2022-06-07 | — | — | CN | claimed |
| CN-112441876-A | Synthetic method of octafluorotoluene | 大连奇凯医药科技有限公司 | 2021-03-05 | — | — | CN | claimed |
| CN-114621178-B | Preparation process of fluoroethylene carbonate | 内蒙古源宏精细化工有限公司 | 2023-10-13 | — | — | CN | disclosed |
| CN-114621178-A | Preparation process of fluoroethylene carbonate | 内蒙古源宏精细化工有限公司 | 2022-06-14 | — | — | CN | disclosed |
| CN-112441876-B | Synthetic method of octafluorotoluene | 大连奇凯医药科技有限公司 | 2022-06-07 | — | — | CN | disclosed |
| CN-112441876-A | Synthetic method of octafluorotoluene | 大连奇凯医药科技有限公司 | 2021-03-05 | — | — | CN | disclosed |
| EP-1945693-B1 | POLYARYLATE-SILOXANE COPOLYMERS | MOMENTIVE PERFORMANCE MAT INC (US) | 2014-08-13 | — | — | EP | disclosed |
| EP-1957558-A2 | POLYARYLATE ACID CHLORIDE COMPOSITIONS AND DERIVATES THEREFROM | General Electric Company (US) | 2008-08-20 | — | — | EP | disclosed |
| EP-1945693-A1 | POLYARYLATE-SILOXANE COPOLYMERS | Momentive Performance Materials Inc. (US) | 2008-07-23 | — | — | EP | disclosed |
| WO-2007070377-A2 | POLYARYLATE ACID CHLORIDE COMPOSITIONS AND DERIVATES THEREFROM | GENERAL ELECTRIC COMPANY (US) | 2007-06-21 | — | — | WO | disclosed |
| US-20070135610-A1 | Polyarylate acid chloride compositions and derivatives therefrom | GENERAL ELECTRIC COMPANY (US) | 2007-06-14 | — | — | US | disclosed |
| WO-2007047083-A1 | POLYARYLATE-SILOXANE COPOLYMERS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2007-04-26 | — | — | WO | disclosed |
| US-20070083026-A1 | Polyarylate-siloxane copolymers | GENERAL ELECTRIC COMPANY (US) | 2007-04-12 | — | — | US | disclosed |
| US-20030163000-A1 | Halogen exchange reactions and catalysts therefor | CHORDIP LTD. (GB) | 2003-08-28 | — | — | US | disclosed |
| EP-1288196-A1 | Process for the preparation of organo guanidinium salts | Chordip Ltd. (GB) | 2003-03-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030163000-A1 | Halogen exchange reactions and catalysts therefor | WEE2, WEE1, SLC39A11 | EHMT2 178/4885EHMT1 287/4885ABCB11 1015/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.